Riskpilot← Back to searchSign inGet full accessVINGMED HOLDING AS
ASActiveOrg 913847326Solbråveien 13, 1383 AskerWholesale of pharmaceutical and medical goods · NACE 4646Est. 20141 employees
Revenue 2024
NOK 10,3M
+131% vs 2023
EBITDA margin
-90.0%
-117% vs 2023
Equity ratio
80.1%
Financial strength
Net profit 2024
NOK 69,4M
+58% vs 2023
| Revenue | NOK 10,3M | +131% |
| EBITDA | NOK -9,2M | -117% |
| Net profit | NOK 69,4M | +58% |
| Total assets | NOK 584,5M | +4% |
| Equity | NOK 468,5M | +17% |
| Employees | 1 | — |
Legal name
VINGMED HOLDING AS
Org number
913847326
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
29. juli 2014
Share capital
NOK 920 800
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap eller styrets leder alene.
Company purpose
Drive utvikling, produksjon og salg av teleteknisk, medisinsk, elektronisk og annet industrielt utstyr, samt annen virksomhet som står i naturlig forbindelse med dette, herunder også deltakelse i og samarbeid med andre selskaper med tilsvarende virksomhet.
Address
Solbråveien 13, 1383 Asker
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 3 872 | 4 404 | 4 440 | 10 271 |
| Staff expenses | −4 205 | −4 683 | −5 616 | −5 825 | −4 392 |
| EBITDA | −7 457 | −1 889 | −2 616 | −4 267 | −9 240 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −7 457 | −1 889 | −2 616 | −4 267 | −9 240 |
| Net financials | 87 659 | 78 683 | 39 412 | 58 450 | 87 356 |
| Profit before tax | 80 201 | 76 794 | 36 795 | 54 183 | 78 116 |
| Tax | 8 945 | 11 318 | 12 850 | 10 343 | 8 752 |
| Net profit | 71 257 | 65 476 | 23 945 | 43 840 | 69 364 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 645 446 | 620 739 | 595 570 | 560 740 | 584 536 |
| Equity | 267 094 | 332 570 | 356 892 | 399 092 | 468 457 |
| Long-term debt | 305 000 | 220 000 | 165 000 | 118 000 | 58 000 |
| Short-term debt | 73 351 | 68 169 | 73 679 | 43 647 | 58 079 |
| Total debt | 378 351 | 288 169 | 238 679 | 161 647 | 116 079 |
EBITDA margin
-90.0%
This company
15.8%
Market median
-670% vs market
20202024
Equity ratio
80.1%
This company
38.2%
Market median
+110% vs market
20202024
Return on equity
14.8%
This company
18.4%
Market median
+20% vs market
20202024
Net profit margin
675.3%
This company
8.1%
Market median
+8237% vs market
20202024
Asset turnover
0.02×
This company
1.12×
Market median
-98% vs market
20202024
Debt / equity
0.25×
This company
0.62×
Market median
+60% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JE Chief Executive Officer | Chief Executive Officer | 2020 |
KH Chief Executive Officer | Chief Executive Officer | 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2025 | |
| Board of Directors | 2022 | |
| Chairman | 2025 | |
| Board of Directors | 2024 | |
| Former (4) | ||
| Chairman | 2022 – 2024 | |
| Chairman | 2024 – 2025 | |
| Board of Directors | 2020 – 2022 | |
| Board of Directors | 2024 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 19.51% | 19.51% | 2022 | |
Robert Lindesj | Company | 19.51% | 19.51% | 2024 |
Nf Invest Aps | Company | 10% | 10% | 2024 |
| Individual | 3.05% | 3.05% | 2024 | |
| Company | 2.91% | 2.91% | 2024 | |
Widlund Utveckling Ab | Company | 1.83% | 1.83% | 2024 |
Orivest Ab | Company | 1.83% | 1.83% | 2024 |
Madsole Randskov | Company | 1.83% | 1.83% | 2024 |
Bente Fabricius Bruun | Company | 1.83% | 1.83% | 2024 |
Mjolp Ab | Company | 1.83% | 1.83% | 2024 |
Ma Sderberg Ab | Company | 1.83% | 1.83% | 2024 |
| Individual | 1.83% | 1.83% | 2022 | |
Jesper Kaiser | Company | 1.83% | 1.83% | 2024 |
Djerf Invest Ab | Company | 1.83% | 1.83% | 2024 |
| Individual | 1.83% | 1.83% | 2024 | |
Søren Galsgaar | Company | 1.83% | 1.83% | 2024 |
Ren Lindemann Frederiksen | Company | 1.83% | 1.83% | 2024 |
| Individual | 1.83% | 1.83% | 2022 | |
| Individual | 1.83% | 1.83% | 2024 | |
| Individual | 1.83% | 1.83% | 2022 | |
Svedenblad Invest Ab | Company | 1.22% | 1.22% | 2024 |
Bengt Malmflt | Company | 1.22% | 1.22% | 2024 |
| Individual | 1.22% | 1.22% | 2024 | |
| Individual | 1.22% | 1.22% | 2024 | |
| Individual | 1.22% | 1.22% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
VINGMED HOLDING AS 
VINGMED ASBoard members of VINGMED HOLDING AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Erik Kirkeby | Chief Executive Officer | 0 companies |
| Kolbjørn Haarr | Chief Executive Officer | 0 companies |
| Anders Thoresen | Chairman | 0 companies |
| Thomas Nordås | Chairman | 0 companies |
| Carl Magnus Torstensson Dahl | Board of Directors | 0 companies |
| Elin Østli-Brandsnes | Board of Directors | 0 companies |
| Elin Østli | Board of Directors | 0 companies |
| Bengt Verner Malmfalt | Board of Directors | 0 companies |
| Marianne Bækkevold | Chairman | 0 companies |
| Tom Edward Pike | Board of Directors | 0 companies |